These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7202366)

  • 1. [Studies on the CNS activity profile of thalidomide analogs (author's transl)].
    Friderichs E
    Arzneimittelforschung; 1982; 32(6):613-20. PubMed ID: 7202366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide.
    Helm FC; Frankus E; Friderichs E; Graudums I; Flohé L
    Arzneimittelforschung; 1981; 31(6):941-9. PubMed ID: 7196239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereoselective differences of central nervous system-depressive action of a homologous series of 3-alkyl-thalidomide analysis].
    Büch HP; Omlor G; Knabe J
    Arzneimittelforschung; 1990 Jan; 40(1):32-6. PubMed ID: 2339997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity of isoproturon, a substituted phenylurea herbicide, in mice.
    Sarkar SN; Gupta PK
    Indian J Exp Biol; 1993 Dec; 31(12):977-81. PubMed ID: 8112777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A neuropharmacological study of isoteolin (IST)].
    Markov M; Zheliazkov D
    Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6.
    Wilimowski M; Witkowska M; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Wojewódzki W; Felsztyńska J
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):569-79. PubMed ID: 1164157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of some 2-N-alkyl-and -aralkyl-3,4:6,7-dibenzomorphans.
    Sharma R; Joshi BC; Dua PR
    Pharmazie; 1980; 35(9):542-3. PubMed ID: 7433504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
    Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T
    Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study of the effect of Acanthopanax giraldii Harms on the central nervous system].
    Deng HZ; Hou LB; Sun SY; Li SY
    Zhongguo Zhong Yao Za Zhi; 1994 Mar; 19(3):171-4, 192. PubMed ID: 7945845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 11. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
    Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacologic properties of pyridoyl derivatives of 3-methylaminoindole 2-methyltryptamine and isotryptamine.
    Misztal S; Wiertek J; Rogóz Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):851-62. PubMed ID: 1015991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the central properties of several Hypericum species from the Canary Islands.
    Prado B; Rabanal RM; Sánchez-Mateo CC
    Phytother Res; 2002 Dec; 16(8):740-4. PubMed ID: 12458477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of some amides of substituted ethylenediamines on central nervous system.
    Sethi OP; Ismail AM; Bhavsar GC; Trivedi BM; Gulati OD
    Indian J Physiol Pharmacol; 1987; 31(2):125-9. PubMed ID: 3666881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution to the pharmacology of a novel neuroleptic drug: flupenthixol (author's transl)].
    van den Driessche J
    Arzneimittelforschung; 1977; 27(11):2121-5. PubMed ID: 580012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and CNS-depressant profile of 3,4,5-trimethoxybenzoyl analogues.
    Kar A
    Pharmazie; 1983 May; 38(5):313-5. PubMed ID: 6611627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
    Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.